Drugs / Control Dendritic Cells
last change Feb 2016 re-read 3 minutes ago

Control Dendritic Cells

Cell therapy

Developed for
type 1 diabetes mellitus
Investigated by
University of Pittsburgh

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00445913 Mar 2007 → Jan 2012 type 1 diabetes mellitus University of Pittsburgh Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Control Dendritic Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT00445913 ↗
Modality Cell therapy “autologous dendritic cell transfer” NCT00445913 ↗